Also, R&D is a potential synergy by the acquirer. If they leave Elite as is the company must continue to invest in R&D. It’s seen as an ongoing need. However, the acquirer could stop R&D, combine with theirs, but that simply means the R&D shifts buckets and you drop a few heads. Bottom line, it doesn’t get excluded. Through all acquisitions I have seen and been part of, R&D has never been ignored.
News 
Market Data 
Discover 
